Prognostic impact of lymphadenectomy in uterine serous cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 4, 2013, Pages 384-391

  Mahdi, H ^a   Kumar, S ^b   Al Wahab, Z ^c   Ali Fehmi, R ^c   Munkarah, A R ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Extent; lymphadenectomy; survival; uterine serous cancer

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; ETHNICITY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; UTERINE SEROUS CANCER; UTERUS CANCER;

ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PREVALENCE; PROGNOSIS; UTERINE NEOPLASMS;

EID: 84873708691     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03431.x     Document Type: Article

References (46)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2000; 60: 277-300.
2. Bokhman JV,. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15: 10-17. (Pubitemid 13194678)
3. Clement PB, Young RH,. Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2004; 11: 117-42.
4. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, et al., Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 2006; 94: 642-6. (Pubitemid 43361894)
5. Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, et al., Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma. Gynecol Oncol 1999; 74: 385-94. (Pubitemid 29439878)
6. Rosenberg P, Boeryd B, Simonsen E,. A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol 1993; 48: 32-7. (Pubitemid 23056183)
7. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R,. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982; 6: 93-108. (Pubitemid 12108965)
8. Lauchlan SC,. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 1981; 105: 615-18. (Pubitemid 11020875)
9. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, et al., Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994; 54: 264-8. (Pubitemid 24301898)
10. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ,. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992; 16: 600-10.
11. Chambers JT, Merino M, Kohorn EI, Peschel RE, Schwartz PE,. Uterine papillary serous carcinoma. Obstet Gynecol 1987; 69: 109-13. (Pubitemid 17205392)
12. O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, et al., Virulence of papillary endometrial carcinoma. Gynecol Oncol 1990; 37: 112-19. (Pubitemid 20147981)
13. Sutton GP, Brill L, Michael H, Stehman FB, Ehrlich CE,. Malignant papillary lesions of the endometrium. Gynecol Oncol 1987; 27: 294-304. (Pubitemid 17158002)
14. Thomas MB, Mariani A, Cliby WA, Keeney GA, Podratz KC, Dowdy SC,. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol 2007; 107: 186-9. (Pubitemid 47575712)
15. Podratz KC, Mariani A,. Uterine papillary serous carcinomas: the exigency for clinical trials. Gynecol Oncol 2003; 91: 461-2. (Pubitemid 38388136)
16. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, et al., Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol 2003; 90: 181-5. (Pubitemid 37338095)
17. Geisler JP, Geisler HE, Melton ME, Wiemann MC,. What staging surgery should be performed on patients with uterine papillary serous carcinoma? Gynecol Oncol 1999; 74: 465-7. (Pubitemid 29439891)
18. Grice J, Ek M, Greer B, Koh WJ, Muntz HG, Cain J, et al., Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol 1998; 69: 69-73. (Pubitemid 28201674)
19. Bristow RE, Asrari F, Trimble EL, Montz FJ,. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease. Gynecol Oncol 2001; 81: 279-86. (Pubitemid 32424175)
20. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK,. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 2009; 373: 125-36.
21. Gehrig PA, Groben PA, Fowler WC Jr, Walton LA, Van Le L,. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol 2001; 97: 153-7. (Pubitemid 32057174)
22. Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, et al., Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol 2004; 95: 469-73. (Pubitemid 39592506)
23. Huh WK, Powell M, Leath CA 3rd, Straughn JM Jr, Cohn DE, Gold MA, et al., Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy. Gynecol Oncol 2003; 91: 470-5. (Pubitemid 38388138)
24. Kelly MG, O'Malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, et al., Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 2005; 98: 353-9. (Pubitemid 41169144)
25. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying)-Linked To County Attributes-Total US, 1969-2006, Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission. [http://www.seercancer.gov]. Last accessed 15 January 2011.
26. Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, Pomel C, Lhommé C, Duvillard P, Castaigne D, et al., Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003; 197: 198-205. (Pubitemid 36927382)
27. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, et al., The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol 2008; 110: 125-32.
28. Ries L, Fritz A,. SEER Extent of Disease-1988, 3rd edn. National Cancer Institute, 1998.
29. Collaborative Staging Task Force of the American Joint Committee on Cancer. Collaborative Staging Manual and Coding Instructions, version 010400. NIH Publication Number 04-5496 Incorporates updates through 8 September 2006, Chicago, IL and Bethesda, MD: American Joint Committee on Cancer and US Department of Health and Human Services, 2004.
30. Seiffert JE,. SEER Program: Comparative Staging Guide for Cancer Version 11. National Cancer Institute, 1988.
31. Creasman WJ,. Announcement, FIGO stages 1988, revisions Gynecol Oncol 1989; 31: 125-7.
32. Gitsch G, Friedlander ML, Wain GV, Hacker NF,. Uterine papillary serous carcinoma. A clinical study. Cancer 1995; 75: 2239-43.
33. Kato DT, Ferry JA, Goodman A, Sullinger J, Scully RE, Goff BA, et al., Uterine papillary serous carcinoma (UPSC): A clinicopathologic study of 30 cases. Gynecol Oncol 1995; 59: 384-9.
34. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N,. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. Lancet 2010 August 21.
35. Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, et al., Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer 2009; 115: 2119-27
36. Wright JD, Lewin SN, Barrena Medel NI, Sun X, Burke WM, Deutsch I, et al., Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome. Gynecol Oncol 2011;Jul;122(1): 69-74.
37. Ahmed A, Zamba G, DeGeest K, Lynch CF,. The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002. Gynecol Oncol 2008; 111: 35-40.
38. Farley JH, Nycum LR, Birrer MJ, Park RC, Taylor RR,. Age-specific survival of women with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2000; 79: 86-9.
39. Hashiguchi Y, Hase K, Ueno H, Shinto E, Naito Y, Kajiwara Y, et al., Impact of race/ethnicity on prognosis in patients who underwent surgery for colon cancer: Analysis for white, African, and East Asian Americans. Ann Surg Oncol 2012;May;19(5): 1517-28.
40. Krag DN, Single RM,. Breast cancer survival according to number of nodes removed. Ann Surg Oncol 2003; 10: 1152-9. (Pubitemid 40486809)
41. Weir L, Speers C, D'Yachkova Y, Olivotto IA,. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 2002; 20: 1793-9. (Pubitemid 34273268)
42. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, et al., Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19: 157-63. (Pubitemid 32063492)
43. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA,. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99: 433-41. (Pubitemid 47073566)
44. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL,. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003; 21: 1029-34. (Pubitemid 46594131)
45. Shah M, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ, et al., Therapeutic role of lymphadenectomy for cervical cancer. Cancer 2011 August 15; 117: 310-17.
46. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al., Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients. Cancer 2006; 107: 1823-30. (Pubitemid 44582951)